Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

AI-based Progression and Medication Response Prediction Study in Parkinson's Disease

NCT07189468 is registered in ClinicalTrials.gov with University Hospital, Toulouse as lead sponsor.

NCT NCT07189468
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07189468 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
AI-based Progression and Medication Response Prediction Study in Parkinson's Disease
Lead sponsor
University Hospital, Toulouse
Phase
Observational
Overall status
Not yet recruiting
Start date
October 6, 2025
Completion date
April 1, 2027
Enrollment
100 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson disease (disorder)